• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

动脉瘤性蛛网膜下腔出血中的严重认知障碍:预测因素及其与功能结局的关系。

Severe cognitive impairment in aneurysmal subarachnoid hemorrhage: Predictors and relationship to functional outcome.

作者信息

Geraghty Joseph R, Lara-Angulo Melissa N, Spegar Milen, Reeh Jenna, Testai Fernando D

机构信息

Department of Neurology and Rehabilitation, College of Medicine, University of Illinois at Chicago, 912 S. Wood St. Suite 174N, Chicago, IL 60612, United States; Medical Scientist Training Program, University of Illinois at Chicago, Chicago, IL, United States.

Department of Neurology and Rehabilitation, College of Medicine, University of Illinois at Chicago, 912 S. Wood St. Suite 174N, Chicago, IL 60612, United States.

出版信息

J Stroke Cerebrovasc Dis. 2020 Sep;29(9):105027. doi: 10.1016/j.jstrokecerebrovasdis.2020.105027. Epub 2020 Jun 20.

DOI:10.1016/j.jstrokecerebrovasdis.2020.105027
PMID:32807442
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7438604/
Abstract

BACKGROUND

Cognitive impairment is common after aneurysmal subarachnoid hemorrhage (SAH). However, compared to predictors of functional outcome, meaningful predictors of cognitive impairment are lacking.

OBJECTIVE

Our goal was to assess which factors during hospitalization can predict severe cognitive impairment in SAH patients, especially those who might otherwise be expected to have good functional outcomes. We hypothesized that the degree of early brain injury (EBI), vasospasm, and delayed neurological deterioration (DND) would predict worse cognitive outcomes.

METHODS

We retrospectively reviewed SAH patient records from 2013 to 2019 to collect baseline information, clinical markers of EBI (Fisher, Hunt-Hess, and Glasgow Coma scores), vasospasm, and DND. Cognitive outcome was assessed by Montreal Cognitive Assessment (MoCA) and functional outcomes by modified Rankin Scale (mRS) at hospital discharge. SAH patients were compared to non-neurologic hospitalized controls. Among SAH patients, logistic regression analysis was used to identify predictors of severe cognitive impairment defined as a MoCA score <22.

RESULTS

We screened 288 SAH and 80 control patients. Cognitive outcomes assessed via MoCA at discharge were available in 105 SAH patients. Most of these patients had good functional outcome at discharge with a mean mRS of 1.8±1.3. Approximately 56.2% of SAH patients had MoCA scores <22 compared to 28.7% of controls. Among SAH patients, modified Fisher scale was an independent predictor of cognitive impairment after adjustment for baseline differences (OR 1.638, p=0.043). MoCA score correlated inversely with mRS (r=-0.3299, p=0.0006); however, among those with good functional outcome (mRS 0-2), 48.7% still exhibited cognitive impairment.

CONCLUSIONS

Severe cognitive impairment is highly prevalent after SAH, even among patients with good functional outcome. Higher modified Fisher scale on admission is an independent risk factor for severe cognitive impairment. Cognitive screening is warranted in all SAH patients, regardless of functional outcome.

摘要

背景

认知障碍在动脉瘤性蛛网膜下腔出血(SAH)后很常见。然而,与功能预后的预测因素相比,缺乏有意义的认知障碍预测因素。

目的

我们的目标是评估住院期间哪些因素可预测SAH患者的严重认知障碍,尤其是那些原本预期功能预后良好的患者。我们假设早期脑损伤(EBI)的程度、血管痉挛和延迟性神经功能恶化(DND)可预测更差的认知预后。

方法

我们回顾性分析了2013年至2019年SAH患者的病历,以收集基线信息、EBI的临床指标(Fisher、Hunt-Hess和格拉斯哥昏迷评分)、血管痉挛和DND。出院时通过蒙特利尔认知评估(MoCA)评估认知预后,通过改良Rankin量表(mRS)评估功能预后。将SAH患者与非神经系统住院对照进行比较。在SAH患者中,采用逻辑回归分析确定严重认知障碍(定义为MoCA评分<22)的预测因素。

结果

我们筛选了288例SAH患者和80例对照患者。105例SAH患者出院时通过MoCA评估了认知预后。这些患者中的大多数出院时功能预后良好,平均mRS为1.8±1.3。约56.2%的SAH患者MoCA评分<22,而对照患者为28.7%。在SAH患者中,调整基线差异后,改良Fisher量表是认知障碍的独立预测因素(OR 1.638,p=0.043)。MoCA评分与mRS呈负相关(r=-0.3299,p=0.0006);然而,在功能预后良好(mRS 0-2)的患者中,48.7%仍存在认知障碍。

结论

SAH后严重认知障碍非常普遍,即使在功能预后良好的患者中也是如此。入院时较高的改良Fisher量表是严重认知障碍的独立危险因素。所有SAH患者均需进行认知筛查,无论其功能预后如何。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c448/7438604/7d1738019821/nihms-1603278-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c448/7438604/5f3c321754f4/nihms-1603278-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c448/7438604/503e83bb2695/nihms-1603278-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c448/7438604/7d1738019821/nihms-1603278-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c448/7438604/5f3c321754f4/nihms-1603278-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c448/7438604/503e83bb2695/nihms-1603278-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c448/7438604/7d1738019821/nihms-1603278-f0003.jpg

相似文献

1
Severe cognitive impairment in aneurysmal subarachnoid hemorrhage: Predictors and relationship to functional outcome.动脉瘤性蛛网膜下腔出血中的严重认知障碍:预测因素及其与功能结局的关系。
J Stroke Cerebrovasc Dis. 2020 Sep;29(9):105027. doi: 10.1016/j.jstrokecerebrovasdis.2020.105027. Epub 2020 Jun 20.
2
Outcome after Hunt and Hess Grade V subarachnoid hemorrhage: a comparison of pre-coiling era (1980-1995) versus post-ISAT era (2005-2014).蛛网膜下腔出血后 Hunt 和 Hess 分级 5 级的预后:在血管内治疗时代前(1980-1995 年)与血管内治疗时代后(2005-2014 年)的比较。
J Neurosurg. 2018 Jan;128(1):100-110. doi: 10.3171/2016.8.JNS161075. Epub 2017 Feb 24.
3
Persistent perioperative hyperglycemia as an independent predictor of poor outcome after aneurysmal subarachnoid hemorrhage.持续性围手术期高血糖作为动脉瘤性蛛网膜下腔出血后不良预后的独立预测因素。
J Neurosurg. 2007 Dec;107(6):1080-5. doi: 10.3171/JNS-07/12/1080.
4
The deleterious effects of methamphetamine use on initial presentation and clinical outcomes in aneurysmal subarachnoid hemorrhage.甲基苯丙胺使用对动脉瘤性蛛网膜下腔出血初始表现和临床结局的有害影响。
J Neurosurg. 2012 Oct;117(4):781-6. doi: 10.3171/2012.7.JNS12396. Epub 2012 Aug 24.
5
Cognitive outcome in acute simvastatin treatment for aneurysmal subarachnoid hemorrhage: A propensity matched analysis.急性辛伐他汀治疗动脉瘤性蛛网膜下腔出血的认知结局:一项倾向匹配分析。
J Neurol Sci. 2015 Nov 15;358(1-2):58-61. doi: 10.1016/j.jns.2015.08.013. Epub 2015 Aug 12.
6
Predictors for Functional Outcome in Patients with Aneurysmal Subarachnoid Hemorrhage Who Completed In-Hospital Rehabilitation in a Single Institution.在单一机构完成住院康复治疗的动脉瘤性蛛网膜下腔出血患者功能预后的预测因素
J Stroke Cerebrovasc Dis. 2019 Jul;28(7):1943-1950. doi: 10.1016/j.jstrokecerebrovasdis.2019.03.042. Epub 2019 Apr 10.
7
Screening tools for early neuropsychological impairment after aneurysmal subarachnoid hemorrhage.动脉瘤性蛛网膜下腔出血后早期神经认知障碍的筛查工具。
Neurol Sci. 2020 Apr;41(4):817-824. doi: 10.1007/s10072-019-04159-w. Epub 2019 Dec 4.
8
Intraventricular extension of an aneurysmal subarachnoid hemorrhage is an independent predictor of a worse functional outcome.动脉瘤性蛛网膜下腔出血的脑室内扩展是功能预后较差的独立预测因素。
Clin Neurol Neurosurg. 2018 Jul;170:67-72. doi: 10.1016/j.clineuro.2018.04.032. Epub 2018 Apr 30.
9
Decreased Superoxide Dismutase Concentrations (SOD) in Plasma and CSF and Increased Circulating Total Antioxidant Capacity (TAC) Are Associated with Unfavorable Neurological Outcome after Aneurysmal Subarachnoid Hemorrhage.血浆和脑脊液中超氧化物歧化酶(SOD)浓度降低以及循环总抗氧化能力(TAC)升高与动脉瘤性蛛网膜下腔出血后不良神经功能结局相关。
J Clin Med. 2021 Mar 12;10(6):1188. doi: 10.3390/jcm10061188.
10
Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.莫西赛利预防蛛网膜下腔出血后血管痉挛相关的迟发性缺血性神经功能缺损和迟发性脑梗死及改善临床结局:一项单中心临床观察性研究
J Neurosurg. 2016 Jan;124(1):51-8. doi: 10.3171/2014.12.JNS13846. Epub 2015 Jul 10.

引用本文的文献

1
SAHRANG: Subarachnoid Hemorrhage Recovery and Galantamine: A Pilot Multicenter Randomized Placebo-Controlled Trial.萨朗:蛛网膜下腔出血康复与加兰他敏:一项多中心随机安慰剂对照试验的初步研究
Neurocrit Care. 2025 Aug 28. doi: 10.1007/s12028-025-02349-3.
2
Are Hippocampal Hypoperfusion and ATP Depletion Prime Movers in the Genesis of Alzheimer's Disease? A Review of Recent Pertinent Observations from Molecular Biology.海马体灌注不足和ATP耗竭是阿尔茨海默病发病的主要因素吗?来自分子生物学的近期相关观察综述
Int J Mol Sci. 2025 Jul 29;26(15):7328. doi: 10.3390/ijms26157328.
3
Neutrophil Integrin α9 Impairs Efferocytosis and Worsens Long-Term Recovery After Subarachnoid Hemorrhage.

本文引用的文献

1
Screening tools for early neuropsychological impairment after aneurysmal subarachnoid hemorrhage.动脉瘤性蛛网膜下腔出血后早期神经认知障碍的筛查工具。
Neurol Sci. 2020 Apr;41(4):817-824. doi: 10.1007/s10072-019-04159-w. Epub 2019 Dec 4.
2
New risk score of the early period after spontaneous subarachnoid hemorrhage: For the prediction of delayed cerebral ischemia.自发性蛛网膜下腔出血后早期新的风险评分:用于预测迟发性脑缺血。
CNS Neurosci Ther. 2019 Oct;25(10):1173-1181. doi: 10.1111/cns.13202. Epub 2019 Aug 12.
3
Return to work after subarachnoid hemorrhage: The influence of cognitive deficits.
中性粒细胞整合素α9损害蛛网膜下腔出血后的噬菌作用并恶化长期恢复。
Arterioscler Thromb Vasc Biol. 2025 Jul 31. doi: 10.1161/ATVBAHA.125.323072.
4
Volume of Aneurysmal Subarachnoid Hemorrhage and Cognitive Outcomes.动脉瘤性蛛网膜下腔出血的体积与认知结果
Neurocrit Care. 2025 Jul 16. doi: 10.1007/s12028-025-02326-w.
5
Multidimensional outcome after endovascular or microsurgical occlusion of ruptured intracranial aneurysms - Comparative analysis of a prospective Swiss multicenter study.破裂颅内动脉瘤血管内或显微手术闭塞后的多维结局——一项瑞士前瞻性多中心研究的比较分析
Brain Spine. 2025 Apr 29;5:104262. doi: 10.1016/j.bas.2025.104262. eCollection 2025.
6
A CoQ10 analog ameliorates cognitive impairment and early brain injury after subarachnoid hemorrhage by regulating ferroptosis and neuroinflammation.一种辅酶Q10类似物通过调节铁死亡和神经炎症改善蛛网膜下腔出血后的认知障碍和早期脑损伤。
Redox Biol. 2025 Jul;84:103684. doi: 10.1016/j.redox.2025.103684. Epub 2025 May 16.
7
FOXO3a-BAP1 axis regulates neuronal ferroptosis in early brain injury after subarachnoid hemorrhage.FOXO3a-BAP1轴调控蛛网膜下腔出血后早期脑损伤中的神经元铁死亡。
Redox Biol. 2025 May;82:103550. doi: 10.1016/j.redox.2025.103550. Epub 2025 Feb 27.
8
Molecular Hydrogen Therapy Enhances Immune Markers in Treg, Plasma, Tr1 Cells, and KLRG1 Expression on Tc Cells: A Case of Acute SDH With Midline Shift and Uncal Herniation Post-decompressive Craniectomy.分子氢疗法增强调节性T细胞、血浆、1型调节性T细胞中的免疫标志物以及细胞毒性T细胞上KLRG1的表达:1例急性硬脑膜下血肿伴中线移位和减压性颅骨切除术后钩回疝的病例
In Vivo. 2025 Mar-Apr;39(2):1190-1199. doi: 10.21873/invivo.13923.
9
Mapping Inflammatory Markers in Cerebrospinal Fluid Following Aneurysmal Subarachnoid Hemorrhage: An Age- and Sex-Matched Analysis.动脉瘤性蛛网膜下腔出血后脑脊液中炎症标志物的映射:一项年龄和性别匹配分析
Int J Mol Sci. 2025 Feb 3;26(3):1302. doi: 10.3390/ijms26031302.
10
A network meta-analysis of different acupuncture therapy in the treatment of poststroke cognitive impairment and dementia.一种网络荟萃分析不同针灸疗法治疗脑卒中后认知障碍和痴呆。
Medicine (Baltimore). 2024 Oct 25;103(43):e40233. doi: 10.1097/MD.0000000000040233.
蛛网膜下腔出血后重返工作岗位:认知缺陷的影响。
PLoS One. 2019 Aug 9;14(8):e0220972. doi: 10.1371/journal.pone.0220972. eCollection 2019.
4
Influence of the Intensive Care Unit Environment on the Reliability of the Montreal Cognitive Assessment.重症监护病房环境对蒙特利尔认知评估可靠性的影响。
Front Neurol. 2019 Jul 3;10:734. doi: 10.3389/fneur.2019.00734. eCollection 2019.
5
Prioritization and Timing of Outcomes and Endpoints After Aneurysmal Subarachnoid Hemorrhage in Clinical Trials and Observational Studies: Proposal of a Multidisciplinary Research Group.动脉瘤性蛛网膜下腔出血后临床试验和观察研究中结局和终点的优先排序和时机:一个多学科研究小组的建议。
Neurocrit Care. 2019 Jun;30(Suppl 1):102-113. doi: 10.1007/s12028-019-00737-0.
6
Neuroinflammation and Microvascular Dysfunction After Experimental Subarachnoid Hemorrhage: Emerging Components of Early Brain Injury Related to Outcome.实验性蛛网膜下腔出血后的神经炎症和微血管功能障碍:与预后相关的早期脑损伤的新兴因素。
Neurocrit Care. 2019 Oct;31(2):373-389. doi: 10.1007/s12028-019-00710-x.
7
Intraventricular Hemorrhage Severity as a Predictor of Outcome in Intracerebral Hemorrhage.脑室内出血严重程度作为脑出血预后的预测指标
Front Neurol. 2019 Mar 12;10:217. doi: 10.3389/fneur.2019.00217. eCollection 2019.
8
Prediction of Outcome After Aneurysmal Subarachnoid Hemorrhage.动脉瘤性蛛网膜下腔出血预后的预测。
Stroke. 2019 Apr;50(4):837-844. doi: 10.1161/STROKEAHA.118.023902.
9
Persistent Malfunction of Glymphatic and Meningeal Lymphatic Drainage in a Mouse Model of Subarachnoid Hemorrhage.蛛网膜下腔出血小鼠模型中淋巴系统和脑膜淋巴引流的持续功能障碍
Exp Neurobiol. 2019 Feb;28(1):104-118. doi: 10.5607/en.2019.28.1.104. Epub 2019 Feb 28.
10
Brain Vasculature and Cognition.脑血管与认知
Arterioscler Thromb Vasc Biol. 2019 Apr;39(4):593-602. doi: 10.1161/ATVBAHA.118.311906.